Literature DB >> 20133926

Chronic cigarette smoke exposure generates pathogenic T cells capable of driving COPD-like disease in Rag2-/- mice.

Gregory T Motz1, Bryan L Eppert, Scott C Wesselkamper, Jennifer L Flury, Michael T Borchers.   

Abstract

RATIONALE: Pathogenic T cells drive, or sustain, a number of inflammatory diseases. Chronic obstructive pulmonary disease (COPD) is an inflammatory lung disease associated with the accumulation of activated T cells. We previously demonstrated that chronic cigarette smoke (CS) exposure causes oligoclonal expansion of lung CD4(+) T cells and CD8(+) T cells in a mouse model of COPD, thus implicating these cells in disease pathogenesis.
OBJECTIVES: To determine whether T cells are pathogenic in a CS-induced mouse model of COPD.
METHODS: We transferred lung CD3(+) T cells from filtered air (FA)- and CS-exposed mice into Rag2(-/-) recipients. Endpoints associated with the COPD phenotype were then measured.
MEASUREMENTS AND MAIN RESULTS: Here, we demonstrate that chronic CS exposure generates pathogenic T cells. Transfer of CD3(+) T cells from the lungs of CS-exposed mice into Rag2(-/-) recipients led to substantial pulmonary changes pathognomonic of COPD. These changes included monocyte/macrophage and neutrophil accumulation, increased expression of cytokines and chemokines, activation of proteases, apoptosis of alveolar epithelial cells, matrix degradation, and airspace enlargement reminiscent of emphysema.
CONCLUSIONS: These data formally demonstrate, for the first time, that chronic CS exposure leads to the generation of pathogenic T cells capable of inducing COPD-like disease in Rag2(-/-) mice. This report provides novel insights into COPD pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20133926      PMCID: PMC2891493          DOI: 10.1164/rccm.200910-1485OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  58 in total

Review 1.  Immunologic aspects of chronic obstructive pulmonary disease.

Authors:  Manuel G Cosio; Marina Saetta; Alvar Agusti
Journal:  N Engl J Med       Date:  2009-06-04       Impact factor: 91.245

2.  Alveolar epithelial cell chemokine expression triggered by antigen-specific cytolytic CD8(+) T cell recognition.

Authors:  M Q Zhao; M H Stoler; A N Liu; B Wei; C Soguero; Y S Hahn; R I Enelow
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

Review 3.  The pathology of smoking-related lung diseases.

Authors:  M C Aubry; J L Wright; J L Myers
Journal:  Clin Chest Med       Date:  2000-03       Impact factor: 2.878

4.  CD4+CD25+Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury.

Authors:  Franco R D'Alessio; Kenji Tsushima; Neil R Aggarwal; Erin E West; Matthew H Willett; Martin F Britos; Matthew R Pipeling; Roy G Brower; Rubin M Tuder; John F McDyer; Landon S King
Journal:  J Clin Invest       Date:  2009-09-21       Impact factor: 14.808

5.  The role of interleukin-1beta in murine cigarette smoke-induced emphysema and small airway remodeling.

Authors:  Andrew Churg; Steven Zhou; Xiaoshan Wang; Rona Wang; Joanne L Wright
Journal:  Am J Respir Cell Mol Biol       Date:  2008-10-17       Impact factor: 6.914

6.  Interleukin-17-mediated immunopathogenesis in experimental hypersensitivity pneumonitis.

Authors:  Amrita D Joshi; Daniel J Fong; Sameer R Oak; Glenda Trujillo; Kevin R Flaherty; Fernando J Martinez; Cory M Hogaboam
Journal:  Am J Respir Crit Care Med       Date:  2009-01-16       Impact factor: 21.405

7.  Lung dendritic cell expression of maturation molecules increases with worsening chronic obstructive pulmonary disease.

Authors:  Christine M Freeman; Fernando J Martinez; MeiLan K Han; Theresa M Ames; Stephen W Chensue; Jill C Todt; Douglas A Arenberg; Catherine A Meldrum; Christi Getty; Lisa McCloskey; Jeffrey L Curtis
Journal:  Am J Respir Crit Care Med       Date:  2009-09-03       Impact factor: 21.405

8.  Sustained CTL activation by murine pulmonary epithelial cells promotes the development of COPD-like disease.

Authors:  Michael T Borchers; Scott C Wesselkamper; Victor Curull; Alba Ramirez-Sarmiento; Albert Sánchez-Font; Judith Garcia-Aymerich; Carlos Coronell; Josep Lloreta; Alvar G Agusti; Joaquim Gea; John A Howington; Michael F Reed; Sandra L Starnes; Nathaniel L Harris; Mark Vitucci; Bryan L Eppert; Gregory T Motz; Kevin Fogel; Dennis W McGraw; Jay W Tichelaar; Mauricio Orozco-Levi
Journal:  J Clin Invest       Date:  2009-02-09       Impact factor: 14.808

9.  STAT4 activation in smokers and patients with chronic obstructive pulmonary disease.

Authors:  A Di Stefano; G Caramori; A Capelli; I Gnemmi; F L Ricciardolo; T Oates; C F Donner; K F Chung; P J Barnes; I M Adcock
Journal:  Eur Respir J       Date:  2004-07       Impact factor: 16.671

10.  Interferon gamma induction of pulmonary emphysema in the adult murine lung.

Authors:  Z Wang; T Zheng; Z Zhu; R J Homer; R J Riese; H A Chapman; S D Shapiro; J A Elias
Journal:  J Exp Med       Date:  2000-12-04       Impact factor: 14.307

View more
  34 in total

1.  Smoking: effects on multiple sclerosis susceptibility and disease progression.

Authors:  Dean M Wingerchuk
Journal:  Ther Adv Neurol Disord       Date:  2012-01       Impact factor: 6.570

2.  Blockade of RAGE ameliorates elastase-induced emphysema development and progression via RAGE-DAMP signaling.

Authors:  Hanbyeol Lee; Jeong-Ran Park; Woo Jin Kim; Isaac K Sundar; Irfan Rahman; Sung-Min Park; Se-Ran Yang
Journal:  FASEB J       Date:  2017-02-01       Impact factor: 5.191

Review 3.  Update in chronic obstructive pulmonary disease in 2010.

Authors:  Meilan K Han
Journal:  Am J Respir Crit Care Med       Date:  2011-05-15       Impact factor: 21.405

4.  Incidence and mortality of obstructive lung disease in rheumatoid arthritis: a population-based study.

Authors:  Carlotta Nannini; Yimy F Medina-Velasquez; Sara J Achenbach; Cynthia S Crowson; Jay H Ryu; Robert Vassallo; Sherine E Gabriel; Eric L Matteson; Tim Bongartz
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-08       Impact factor: 4.794

5.  Cigarette smoke induction of osteopontin (SPP1) mediates T(H)17 inflammation in human and experimental emphysema.

Authors:  Ming Shan; Xiaoyi Yuan; Li-Zhen Song; Luz Roberts; Nazanin Zarinkamar; Alexander Seryshev; Yiqun Zhang; Susan Hilsenbeck; Seon-Hee Chang; Chen Dong; David B Corry; Farrah Kheradmand
Journal:  Sci Transl Med       Date:  2012-01-18       Impact factor: 17.956

6.  Experimental therapeutics of Nrf2 as a target for prevention of bacterial exacerbations in COPD.

Authors:  Shyam Biswal; Rajesh K Thimmulappa; Christopher J Harvey
Journal:  Proc Am Thorac Soc       Date:  2012-05

7.  Microarray analysis of long non-coding RNAs in COPD lung tissue.

Authors:  Hui Bi; Ji Zhou; Dandan Wu; Wei Gao; Lingling Li; Like Yu; Feng Liu; Mao Huang; Ian M Adcock; Peter J Barnes; Xin Yao
Journal:  Inflamm Res       Date:  2014-12-27       Impact factor: 4.575

8.  NKG2D Regulation of Lung Pathology and Dendritic Cell Function Following Respiratory Syncytial Virus Infection.

Authors:  Huan Liu; Andrew R Osterburg; Jennifer Flury; Shuo Huang; Francis X McCormack; Stephania A Cormier; Michael T Borchers
Journal:  J Infect Dis       Date:  2018-10-20       Impact factor: 5.226

9.  MAPK mutations and cigarette smoke promote the pathogenesis of pulmonary Langerhans cell histiocytosis.

Authors:  Huan Liu; Andrew R Osterburg; Jennifer Flury; Zulma Swank; Dennis W McGraw; Nishant Gupta; Kathryn A Wikenheiser-Brokamp; Ashish Kumar; Abdellatif Tazi; Yoshikazu Inoue; Masaki Hirose; Francis X McCormack; Michael T Borchers
Journal:  JCI Insight       Date:  2020-02-27

10.  Functional characterization of T cell populations in a mouse model of chronic obstructive pulmonary disease.

Authors:  Bryan L Eppert; Brian W Wortham; Jennifer L Flury; Michael T Borchers
Journal:  J Immunol       Date:  2012-12-21       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.